Your browser does not support iframes.
Miami Herald Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Drugs - Generic Sector
(CIX:
MSECTOR512
)
2,421.90
+54.10 (+2.28%)
Streaming Delayed Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Sector
Overview
Sub-Sectors
Sub-Sector Map
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
All news about Drugs - Generic Sector
< Previous
1
2
3
4
5
6
7
Next >
DEALTALK: Warner Chilcott buy may be Actavis' best takeover defense
May 17, 2013
NEW YORK, May 17 (Reuters) - U.S. generic drugmaker Actavis , the subject of intense takeover speculation, may have found its best defense: a potential purchase of Warner Chilcott Plc, a specialty...
Read More
category
companyNews
from
Reuters: Company News
Mylan (MYL) Launches Generic Tricor Tabs (ABBV)
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8349783 for the full story.
Read More
from
StreetInsider.com News Articles
Mylan Launches Generic Tricor® Tablets
May 17, 2013
from
PR Newswire
(GSK) GlaxoSmithKline’s Trametinib Delayed
May 16, 2013
Recently, GlaxoSmithKline (GSK) announced that the US Food and Drug Administration (FDA) has... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Athersys Inc
,
Healthcare
, and 5 more.
from
Stock Blog Hub
(VRX) Valeant Pharmaceuticals Beats Earnings – Misses Revenues
May 16, 2013
Valeant Pharmaceuticals’ (VRX) first quarter 2013 earnings of $1.27 (excluding special items but... Visit StockBlogHub to view complete post.
Read More
category
ONXX
,
Mylan Inc/
,
Onyx Pharmaceuticals Inc
, and 5 more.
from
Stock Blog Hub
NASDAQ Gainers Watch List: Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Mylan, Inc. (NASDAQ:MYL) Added to Growing Stock Report's NASDAQ Gainers Watch List.
May 16, 2013
New York, NY -- (SBWIRE) -- 05/16/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Halozyme Therapeutics, Inc. (NASDAQ:HALO) and Mylan, Inc. (NASDAQ:MYL).
Read More
from
SBWire - Latest Press Releases
Novartis says has no intention of buying Actavis
May 16, 2013
ZURICH, May 16 (Reuters) - Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on...
Read More
category
companyNews
from
Reuters: Company News
Catyalyst Pharmaceutical (CPRX) Posts Narrower than Expected Q1 Loss
May 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8345851 for the full story.
Read More
from
StreetInsider.com News Articles
Catalyst Pharmaceutical Partners Reports First Quarter 2013 Financial Results
May 16, 2013
from
GlobeNewswire News Releases
Early Movers: WMT, KSS, CSCO & More
May 16, 2013
These are the stocks posting the largest moves before the bell.
Read More
category
General Electric
,
Advanced Micro Devices Inc
,
Dow Chemical Co
, and 29 more.
from
CNBC.com News
(ARIA) Ariad Pharmaceuticals Posts Wider Year Over Year Loss
May 15, 2013
Ariad Pharmaceuticals, Inc. (ARIA) reported first quarter loss of 36 cents per share, wider than... Visit StockBlogHub to view complete post.
Read More
category
SNTS
,
Biotechnology
,
Lannett Company Inc
, and 13 more.
from
Stock Blog Hub
Perfect Trade Setups, How to Play LUV, CMCSA, XOM and MYL
May 15, 2013
from
Marketwired News Releases
(IPXL) Impax Laboratories Beats Earnings Estimate
May 15, 2013
Impax Laboratories Inc.’s (IPXL) first quarter 2013 adjusted earnings of 37 cents per share were... Visit StockBlogHub to view complete post.
Read More
category
Glaxosmithkline plc
,
Transcept Pharmaceuticals Inc
,
CPRX
, and 7 more.
from
Stock Blog Hub
Mylan (MYL) Unit Launches Generic Zomig Tabs
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8341139 for the full story.
Read More
from
StreetInsider.com News Articles
Mylan Launches Generic Zomig® Tablets
May 15, 2013
from
PR Newswire
Early Movers: DE, BA, GOOG, GPS & More
May 15, 2013
These are the stocks posting the largest moves before the bell.
Read More
category
Economics
,
tvcodes/tvearn
,
tvcodes/tvearnings
, and 19 more.
from
CNBC.com News
Market Chatter-Corporate finance press digest
May 15, 2013
May 15 (Reuters) - The following corporate finance-related stories were reported by media on Wednesday:
Read More
category
companyNews
from
Reuters: Company News
Actavis rejected $15 billion offer from Mylan - source
May 14, 2013
NEW YORK, May 14 (Reuters) - Actavis Inc received and rejected a takeover offer from Mylan Inc last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation...
Read More
category
companyNews
from
Reuters: Company News
Benzinga's M&A Chatter for Tuesday May 14, 2013
May 14, 2013
The following are the M&A deals, rumors and chatter circulating on Wall Street for Tuesday May 14, 2013: Actavis Reportedly Rejected $120/Share Mylan Bid The Rumor:Actavis (NYSE: ACT ) reportedly...
Read More
category
Rumors
,
Benzinga
,
Movers
, and 9 more.
from
Latest Articles from Benzinga.com
NASDAQ Active Stock Watch List: Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Unilife Corporation (NASDAQ:UNIS), and Mylan, Inc. (NASDAQ:MYL) Added to Equity Profile Report's NASDAQ Active Stock Watch
May 14, 2013
Wilmington, DE -- (SBWIRE) -- 05/14/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), Unilife Corporation...
Read More
from
SBWire - Latest Press Releases
(ACT) Actavis Beats on Earnings – Raises View
May 14, 2013
Actavis, Inc.’s (ACT) first quarter 2013 earnings of $1.99 per share beat the Zacks Consensus... Visit StockBlogHub to view complete post.
Read More
category
ACT
,
Healthcare
,
Drugs / Generic
, and 3 more.
from
Stock Blog Hub
Warner Chilcott (WCRX) Volatile as Actavis (ACT) Has a New Bidder
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8336254 for the full story.
Read More
from
StreetInsider.com News Articles
Actavis (ACT) said to have turned away $15 billion bid from Mylan (MYL) - Bloomberg
May 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8336201 for the full story.
Read More
from
StreetInsider.com News Articles
Large Cap Movers (Sequenom, Catalyst Pharmaceutical Partners, Yingli Green Energy Hold, Actavis Inc)
May 13, 2013
Austin, TX -- (SBWIRE) -- 05/13/2013 -- Jackpotpennystocks.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues...
Read More
from
SBWire - Latest Press Releases
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Mylan, Inc. (NASDAQ:MYL), and Intuitive Surgical, Inc. (NASDAQ:ISRG) Added to Equity Profile Report's NASDAQ Active Stock Watch List.
May 10, 2013
Wilmington, DE -- (SBWIRE) -- 05/10/2013 -- Equity Profile Report expands its NASDAQ Active Stock Weekly Watch List adding Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), Mylan, Inc. (NASDAQ:MYL), and...
Read More
from
SBWire - Latest Press Releases
Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy
May 10, 2013
More Than 65 Family-Friendly Walks Raise Food Allergy Awareness
Read More
from
PR Newswire
Notable Analyst Rating Changes 05/10: (FST) (EIX) (BSX) Upgraded; (MDR) (DNDN) (LTD) Downgraded
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8326447 for the full story.
Read More
from
StreetInsider.com News Articles
BMO Capital Starts Mylan (MYL) at Underperform
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8325520 for the full story.
Read More
from
StreetInsider.com News Articles
Janney Montgomery Scott Starts Mylan (MYL) at Buy
May 09, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8324826 for the full story.
Read More
from
StreetInsider.com News Articles
Thursday's ETF with Unusual Volume: XPH
May 09, 2013
The SPDR S&P Pharmaceuticals ETF (XPH) is seeing unusually high volume in afternoon trading Thursday, with over 274,000 shares traded versus three month average volume of about 26,000. Shares of XPH...
Read More
category
ETFs
from
ETF Channel
< Previous
1
2
3
4
5
6
7
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.
Your browser does not support iframes.